10X Genomics, Inc. (TXG)
63.79
-1.33
(-2.04%)
USD |
NASDAQ |
Aug 24, 16:00
63.79
0.00 (0.00%)
After-Hours: 20:00
10X Genomics Price to Book Value : 10.07 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 10.28 |
| August 20, 2026 | 10.08 |
| August 19, 2026 | 9.814 |
| August 18, 2026 | 8.779 |
| August 17, 2026 | 9.152 |
| August 14, 2026 | 8.852 |
| August 13, 2026 | 9.177 |
| August 12, 2026 | 9.114 |
| August 11, 2026 | 9.229 |
| August 10, 2026 | 9.243 |
| August 07, 2026 | 8.211 |
| August 06, 2026 | 7.196 |
| August 05, 2026 | 7.490 |
| August 04, 2026 | 7.553 |
| August 03, 2026 | 7.419 |
| July 31, 2026 | 7.460 |
| July 30, 2026 | 7.801 |
| July 29, 2026 | 7.310 |
| July 28, 2026 | 7.425 |
| July 27, 2026 | 7.247 |
| July 24, 2026 | 7.302 |
| July 23, 2026 | 7.584 |
| July 22, 2026 | 7.425 |
| July 21, 2026 | 7.449 |
| July 20, 2026 | 6.821 |
| Date | Value |
|---|---|
| July 17, 2026 | 6.903 |
| July 16, 2026 | 7.020 |
| July 15, 2026 | 7.22 |
| July 14, 2026 | 7.226 |
| July 13, 2026 | 6.592 |
| July 10, 2026 | 6.743 |
| July 09, 2026 | 6.802 |
| July 08, 2026 | 5.913 |
| July 07, 2026 | 5.970 |
| July 06, 2026 | 6.312 |
| July 02, 2026 | 6.156 |
| July 01, 2026 | 6.163 |
| June 30, 2026 | 6.051 |
| June 29, 2026 | 5.884 |
| June 26, 2026 | 5.821 |
| June 25, 2026 | 5.660 |
| June 24, 2026 | 5.481 |
| June 23, 2026 | 5.048 |
| June 22, 2026 | 5.218 |
| June 18, 2026 | 5.505 |
| June 17, 2026 | 5.089 |
| June 16, 2026 | 5.029 |
| June 15, 2026 | 5.104 |
| June 12, 2026 | 4.568 |
| June 11, 2026 | 4.602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 19.79 |
| Alamar Biosciences, Inc. (California) | 7.261 |
| Personalis, Inc. | 7.726 |
| Adaptive Biotechnologies Corp. | 28.43 |
| Champions Oncology, Inc. | 17.59 |
Price to Book Value Related Metrics
| PS Ratio | 13.21 |
| Price to Free Cash Flow | 67.09 |
| Price | 63.79 |
| Earnings Yield | -0.92% |
| Market Cap | 8.311B |